✦ LIBER ✦

Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia

✍ Scribed by Jan Törling; Jonas Hedlund; Helle Bossen Konradsen; Åke Örtqvist

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised trial of 23-valent pneumococc

✍ Åke Örtqvist; Jonas Hedlund; Lars-Åke Burman; Elisabet Elbel; Margareta Höfer; M 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 86 KB

Clinical effectiveness of 23-valent pneu

✍ Angel Vila-Corcoles; Elisabet Salsench; Teresa Rodriguez-Blanco; Olga Ochoa-Gond 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 158 KB

PIN74 A Cost-Effectiveness Analysis of V

✍ Y. Jiang; A. Gauthier; L. Annemans; M. van der Linden; L. Nicolas-Spony; X. Bres 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PIN17 Modelling Budget Impact (BI) of Va

✍ Y. Jiang; A. Gauthier; L. Annemans; M. van der Linden; L. Nicolas-Spony; X. Bres 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

The 23-Valent Pneumococcal Polysaccharid

✍ Alessia Melegaro; W. John Edmunds 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 130 KB

PIN64 Assessing the Cost-Effectiveness (

✍ Y. Jiang; A. Gauthier; S.T. Keeping; S.M. Carroll 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB